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St reszczenie
Pierwotne miêsaki serca s¹ wyj¹tkowo rzadkimi guzami.
Dotychczas nie opisano przerzutu pierwotnego miêsaka ser-
ca do mózgu. Chocia¿ wiadomo wiele o przerzutach pier-
wotnych nowotworów z³oœliwych do mózgu, to nigdy
wczeœniej nie opisano przerzutów miêsaka wrzecionowa-
tokomórkowego przedsionka do mózgu. Guzy te z wiêkszym
prawdopodobieñstwem mog¹ dawaæ przerzuty drog¹ krwi do
p³uc lub w¹troby.
W pracy opisano przypadek m³odego mê¿czyzny, u którego
9 lat wczeœniej wyst¹pi³ guz przerzutowy mózgu, którego
Ÿród³em by³ miêsak wrzecionowatokomórkowy lewego 
przedsionka. Po leczeniu chirurgicznym przeprowadzono
napromienianie ca³ego mózgowia dawk¹ 30 Gy. W póŸ -
niejszym czasie u chorego wyst¹pi³a miejscowa wznowa guza
lewego przedsionka, której towarzyszy³o migotanie przed-
sionków i niedomykalnoœæ zastawki dwudzielnej.
Przedstawiony przypadek jest pierwszym opisem rzeczywis-
tego przerzutu pierwotnego miêsaka serca do mózgu. Nie ma
zatem ustalonych zasad postêpowania. W miarê mo¿liwoœci
wskazane by³oby publikowanie kolejnych opisów przypad-
ków lub ich serii.
S³owa kluczowe: pierwotny miêsak serca, przerzut do mózgu,
niedomykalnoœæ zastawki dwudzielnej, chemioterapia neoad-
juwantowa, chemioterapia adjuwantowa.
Abst rac t
Primary cardiac sarcomas are exceptionally rare tumours.
A brain metastasis of a primary cardiac sarcoma has never
been reported before. Although we know lots of primary
malignomas spreading to the brain, we never observed cere-
bral metastases of an atrial spindle cell sarcoma. Cardiac sar-
comas are more likely to haematogenously metastasize to the
lung or the liver.
Here, we describe the case of a young man, who suffered
from a cerebral metastasis of a spindle cell sarcoma in the left
heart atrium nine years ago. Postoperative whole brain irra-
diation with 30 Gy was performed. Later on, the patient expe-
rienced a local recurrence within the left atrium accompanied
by cardiac arrhythmia and mitral valve insufficiency.
This case is the very first description of a true cerebral metas-
tasis from a primary heart sarcoma. Therefore, clear treat-
ment paradigms are not established. Further case illustrations
and the publication of larger patient series are mandatory,
whenever possible.
Key words: primary cardiac sarcoma, brain metastasis, mitral
valve insufficiency, neoadjuvant chemotherapy, adjuvant
chemotherapy.
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Introduction
Primary cardiac malignomas are exceptionally rare
tumours with a low prevalence of 0.002-0.28% [1].
A few institutions report of small groups [4-6] or even
single cases [8-16]. In particular, spindle cell sarcomas
and leiomyosarcomas of cardiovascular origin are
extremely rare. About half of all cardiac sarcomas are
situated in the left atrium [8,9,12,13]. Due to the
extreme rareness of cardiac spindle cell sarcomas, there
is no general experience in their management [5,11,12].
Nevertheless, sarcomas are the most common primary
cardiac tumours and include leiomyosarcomas, rhab-
domyosarcomas, myxosarcomas, angiosarcomas, liposar-
comas, fibrosarcomas, osteosarcomas, neurofibrosarco-
mas, spindle cell sarcomas, malignant fibrous
histiocytomas, synovial sarcomas, and undifferentiated
sarcomas [1-6,12,16,17].
A few reports describe Ebstein-Barr virus-associat-
ed leiomyosarcomas of the heart in immunosuppressed
patients [18,19,21]. The typical symptoms of heart
tumours include intracardiac obstruction, signs of sys-
temic embolization, and systemic or constitutional symp-
toms. Serious complications are ischaemic stroke,
myocardial infarction and even sudden death
[1,5,6,14,21]. Despite surgical tumour resection of
heart sarcomas and subsequent adjuvant treatment, the
prognosis of malignant cardiac tumours remains poor,
with a median survival of about 25 months
[5,6,9,12,17]. Still, the knowledge about primary car-
diac sarcomas remains very restricted.
Brain metastases are known to occur in a lot of malig-
nant tumours. Although we can readily imagine cardiac
sarcomas as frequently spreading to the brain, central
metastases have never been reported except for one case
illustration describing a central metastasis of a histiosar-
coma [10]. Here, we report the first case of a young man
with a highly malignant primary cardiac spindle cell sar-
coma and subsequent cerebral metastasis.
Case report
A young man experienced an intermittent absolute
cardiac arrhythmia in November 1996. Starting in
October 1998, the patient repeatedly suffered from visu-
al deficits, headache, vertigo, sensory deficits in his face
and upper and lower extremities, a reduced producti-
vity, generalized weakness, and fever up to 39.5°C. In
the blood test, an enhanced erythrocyte sedimentation
rate was found. Echocardiography revealed a globular
tumour within the left atrium that was confirmed by
electrocardiogram-triggered magnetic resonance imag-
ing (MRI) of the heart (Fig. 1, part A). The tumour
was surgically removed in December 1998 by means of
a partial septectomy within healthy tissue margins as
a so-called R0 resection.
Histopathologically, the diagnosis of a primary high-
ly malignant spindle cell sarcoma of the left atrium was
made. The additional oncological screening did not
show any further tumour manifestations in the patient’s
body.
Only 14 months later, the patient suffered from focal
epileptic seizures, headache, and a sensory loss in the
left lower extremity. In addition, muscle stretch reflex-
es of the left lower extremity were weaker than on the
right side. Cranial imaging with computed tomography
(CT) revealed bleeding in the right central region of the
brain. MRI with the intravenous administration of
gadolinium-DTPA demonstrated a right-sided lesion
within the central cerebral region with an irregular
gadolinium enhancement at the lesion’s margins,
a hypointense centre of the lesion, and a perifocal brain
oedema (Fig. 1, parts B-D). The cerebral angiography
demonstrated a high vascularization of the lesion (Fig. 1,
part E). This high vascularization was pronounced in
the vicinity of the superior sagittal sinus. Screening for
a cardiac tumour recurrence or distant metastases using
transoesophageal sonography, thoracic CT, and selec-
tive proximal angiography of the heart and the pul-
monary vessels did not reveal any further tumour
lesions.
Intracranial tumour bulk removal was performed in
April 2000 with the aid of a multiplanar neuronaviga-
tion system and by the use of continuous intraoperative
neuromonitoring with direct cortical stimulation to local-
ize the central region by phase inversion (Fig. 2). Post-
operatively, the patient received percutaneous whole
brain irradiation with a total dose of 30 Gy until May
2000. In November 2000, the patient developed new
cardiac arrhythmia. The consecutive imaging demon-
strated a new tumour mass within the left atrium and
local lymph node metastases within the mediastinum
(Fig. 1, part H). This time, surgical resection was per-
formed including a reconstruction of the cardiac sep-
tum between both atria by the use of a pericardial patch.
Following surgery of this local tumour recurrence, per-
cutaneous irradiation of the left atrium including the
proximal pulmonary artery was performed up to a total
dose of 50 Gy. Later on, the patient developed slight
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insufficiency of the aortic valve and insufficiency of 
the mitral valve, cardiac fibrillation, and dyspnoea dur-
ing daily life activities according to the NYHA grades
II–III. The progressive insufficiency of the mitral valve
made a biological replacement necessary that was per-
formed in March 2007 and was followed by implanta-
tion of a pacemaker because of a postoperative atrioven -
tricular block grade III. A postoperative haematothorax
in May 2007 was treated by repeated thoracotomies.
Currently, the patient is in a stabilized condition and
shows no signs of recurrent tumour or any distant meta-
stases.
Histopathological evaluation
Brain tumour material was fixed with 6% para -
formaldehyde. Tumour tissue slices were established at
a thickness of 4 μm. Histopathological workup was per-
formed with H&E staining and subsequent immuno-
histochemistry. Primary antibodies were used to label
Ki67, vimentin, desmin, ASMA, S100, HHF-35, MNF,
and CD31.
Histopathological workup of brain metastasis mate-
rial revealed a highly cellular and vascularized tumour
with about 5% to 10% mitoses per high power field 
(Fig. 3, parts A-D). Tumour cell invasion into the sur-
rounding brain parenchyma was visible in some areas
(Fig. 3, part A) in contrast to a sharp tumour-brain bor-
der in other areas (Fig. 3, part B). Tumour necroses were
not observed. In the resected tumour material, pleo-
morphic and partly vesicularly transformed cell nuclei
could clearly be seen. Furthermore, atypical mitoses were
visible. The tumour cells themselves were of a spindle
cell type and only partly of a polygonal shape. The
tumour tissue showed older and fresh bleeding. Tumour
cell staining was negative for HHF-35, ASMA, MNF,
and desmin. Immunopositivity was only detected for
vimentin (Fig. 3, part F). The proliferative activity, eval-
uated by the Ki67 positivity of the metastasis, was esti-
mated between 5% and 10% (Fig. 3, part E).
Histopathological workup of local recurrence of the
primary cardiac spindle cell sarcoma showed S100 nega -
tivity (Fig. 4, part A) and CD31 negativity of the
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Fig. 1. Imaging studies of the patient’s primary cardiac sarcoma, the brain
metastasis, and the later occurring local lymph node metastases during a local
atrial recurrence. (A) The electrocardiogram-triggered thoracic MRI demon-
strates the globular lesion within the left atrium. The signal of the tumour
enhanced irregularly after gadolinium injection (arrowheads). (B-D) The cra-
nial MRI after intravenous administration of gadolinium-DTPA shows the tumour
mass with an enhancement at the tumour margins in addition to the bloody
component that is visible in the T1-weighted sequences without gadolinium
injection. The tumour shows a clear perifocal oedema and is located within
the right central region. (E) The preoperative cerebral angiography demon-
strates the strong vascularization of the tumour and its direct vicinity to the
superior sagittal sinus. (F, G) The postoperative cranial imaging illustrates
completely regular conditions immediately after the operation (F) and two
years later (G). After pacemaker implantation in 2007, cranial imaging only
can be performed by means of CT. (H) A mediastinal lymph node metastasis
that was detected among other local lymph node metastases at the end of the
year 2000 is shown in the small inset of picture A (arrowhead)
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tumour cells (Fig. 4, part C). Furthermore, tumour cells
were negative for desmin. In contrast to the brain metas-
tasis, tumour cells of the cardiac recurrence were posi-
tive for the smooth muscle actin ASMA (Fig. 4, 
part B). The Ki67 labelling index was evaluated to be
about 5% to 10% (Fig. 4, part D).
Discussion
Malignant primary cardiac tumours and even sar-
comas of the heart are significantly less common than
metastatic tumour disease to the heart [5,17,22]. Espe-
cially pulmonary and uterine leiomyosarcomas were
reported to spread to the heart [16,23], but carcinomas
spread significantly more often into the cardiac region
than sarcomas do [23]. Among cardiac sarcomas,
angiosarcomas and unclassified sarcomas most often
grow within the heart muscle itself [5]. In a series of
1429 sarcoma patients, only 14 patients suffered from
a cardiac sarcoma [6]. These 14 patients were charac-
terized by their young age and a poor prognosis of only
a few months after the initial diagnosis [6].
Echocardiography and angiography are the essen-
tial diagnostic tools for cardiac sarcomas. Technical
improvements in the performance of CT and MRI
(Fig. 1) have enhanced their impact in the diagnostic
approach within the last decade [17]. Whenever pos-
sible, total surgical resection is performed [2]. Despite
local tumour surgery, subsequent irradiation, adjuvant
chemotherapy, and even cardiac transplantation, the
prognosis for the affected patients generally remains
extremely poor [6]. The benefit of adjuvant chemothe -
rapy was controversially discussed during the last years
[2,3,7,14,19,22,26,31,35]. Whereas chemotherapy was
not performed in early years, current treatment strate-
gies include surgery, irradiation, and chemotherapy.
Only a few reports describe an unclear effect of adju-
vant chemotherapy [31,35]. Some authors even report
Fig. 2. Intraoperative situs and neuromonitoring during the surgical procedure. (A) The tumour resection cavity is bordered by the central sulcus with the rolandic vein
(smaller arrowhead). The electrode from the direct cortical electric stimulation is visible as well (larger arrowhead). The former tumour circumference is labelled by the
yellow line. (B) The image of phase inversion is demonstrated and the region of this phase inversion is marked by a yellow arrowhead. (C) This picture illustrates the
intraoperative direct cortical stimulation performed with up to eight electrodes located on the cerebral cortex as shown by the larger arrowhead in (A)
A B
C
Neurologia i Neurochirurgia Polska 2010; 44, 2192
that the adjuvant chemotherapy and irradiation have no
effect on long-term survival [31]. In principle, prima-
ry cardiac sarcomas are uniformly associated with poor
long-term survival. According to the current point of
view, cardiac sarcomas should be treated by extensive
surgical excision followed by adjuvant radiation and
chemotherapy. This strategy may improve survival with
a good quality of life. Even heart transplantation is
Fig. 3. Histopathological workup and immunohistochemistry of the brain metastasis of the atrial spindle cell sarcoma. (A-D) H&E staining of the tumour tissue illus-
trates the aggressive morphology. The tumour tissue is highly cellular and vascularized and demonstrates polygonal and spindle-like tumour cells with strongly pleo-
morphic cell nuclei. Atypical mitoses are visible. (A) Bar indicates 500 μm. (B) Bar indicates 100 μm. (C, D) Bars indicate 20 μm. (E) The Ki67 labelling indicates
a proliferative activity of 5% to 10% of the tumour cells. Bar indicates 100 μm. (F) The tumour cells are positive for vimentin. Bar indicates 500 μm
A B
C D
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Fig. 4. Local atrial recurrence of the spindle cell sarcoma. (A) The tumour cells are negative for the S100 protein. Bar indicates 100 μm. (B) Tumour tissue is strong-
ly positive for ASMA, the smooth muscle actin. Bar indicates 100 μm. (C) Endothelial cells of tumour blood vessels are positive for CD31. Tumour cells were negatively
tested for the expression of this antigen. Bar indicates 100 μm. (D) Ki67 positivity indicates 5% to 10% of the tumour cells to be within the proliferative stage. Bar
indicates 100 μm
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a therapeutic option in primary cardiac sarcomas with-
out metastatic disease.
The extent of resection has the main impact on sur-
vival, but adjuvant therapy can improve patients’ out-
come significantly [3,7,19,31,35]. There were no local
recurrences observed in patients with R0 resection [2].
Neoadjuvant chemotherapy can be performed prior to
surgery [7]. This simplifies the subsequent surgery sig-
nificantly [3,7].
The most often used chemotherapeutics are doxo -
rubicin, ifosfamide, and gemcitabine [2,14,19]. In some
cases, docetaxel and mesran are included in the
chemotherapeutic regimen [14,19]. Although our case
presents only the second real cerebral metastasis of a pri-
mary cardiac sarcoma, one could imagine brain metas-
tases to display a greater incidence. Neoadjuvant or
adjuvant chemotherapy could help to avoid this usual-
ly fatal complication. 
Metastases of cardiac leiomyosarcomas have been
described to occur within the lung, the local lymph
nodes and more distantly within the liver [5]. Metas-
tases of malignant cardiac spindle cell sarcomas have
been reported within the gastrointestinal tract and local
lymph nodes [4,5,12], but not in the brain. Addition-
ally, sarcomas of other organs rarely metastasize to the
brain [23-25,27-30,32-34,36]. The current biomedical
literature contains 11 publications reporting 14 cases of
non-cardiac leiomyosarcomas that metastasized to the
brain [23-25,27-30,32-34,36]. In only one case did the
brain metastasis originate from a malignant cardiac my -
xoma [23-25,27-30,32-34,36,37]. A malignant prima-
ry cardiac spindle cell sarcoma, metastatic to the brain,
has never been described before. The primary sites of
the above-mentioned non-cardiac malignant sarcomas
metastatic to the brain were the uterus in 13 females and
the gastrointestinal tract in one male patient [23-25,27-
30,32-34,36,37]. All of them were described to be
leiomyosarcomas. The reported cases of uterine
leiomyosarcoma metastases to the brain were charac-
terized by a poor prognosis, with survival no longer than
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2.5 years [33]. Taken together, cerebral metastases of
primary cardiac sarcoma were described in only one
more case.
We have described a young man with a highly malig-
nant cardiac spindle cell sarcoma, who developed a brain
metastasis shortly after initial treatment for the heart
tumour. Currently – after eight years – the patient
remains free of local recurrence or a second brain metas-
tasis. The limiting factor in the patient’s disease is his
heart dysfunction that was worsened by severe mitral
valve insufficiency and an atrioventricular blockade.
Cerebral metastases of a primary cardiac sarcoma –
a spindle cell sarcoma in our case – are an extremely rare
complication. With optimal treatment, the survival rate
of affected patients can be much higher than described
in the literature. Chemotherapeutic strategies should be
included in a multidisciplinary approach to avoid
metastatic spread to the brain.
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